The FDA-approved GLP-1 receptor agonists are exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and efpeglenatide (Eperzan)
These protective benefits have been observed in the GI tract, liver, cardiovascular system, and brain [20, 36]
However, despite its promising mechanisms, AOD-9604 is not FDA-approved for medical use
Depending on the value of the shape parameter , the upper limit of the 95% confidence interval (CI) for 1 demonstrates an increasing hazard over time (wear-out failure type), whereas the 95% CI includes 1 for , suggesting a constant hazard rate throughout the exposure period (random failure type)
Examination: Exam +/- pH/microscopy/NAATs
Ozempic costs $998 per month without insurance or $299 after insurance